Ramdeo Agarwal

5 High Dividend Yield Stocks For Your Portfolio

Staff Reporter September 26, 2010

The masters of stock investment from Rakesh Jhunjhunwala to Warren Buffett advocate buying shares...

South Indian Bank:Ramdeo Agarwal’s multi-bagger stock?

Staff Reporter July 26, 2010

Master stock-picker Ramdeo Agarwal's latest investment is in South Indian Bank. We run South...
Read More

Posts pagination

Previous 1 2 3

Subscribe to Telegram Channel
Click here
Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address

Join 582 other subscribers

Recent Comments
Kamal Garg on LG Electronics is India’s leading home appliances brand & has retained pole position across categories. Buy for target price of ₹1630 (18.9% upside): JMFICS
Kamal Garg on Suzlon Energy Risk-reward is favorable at current levels. Buy for target price of ₹74 (54% upside): Motilal Oswal
Mukul on LG Electronics is a high-quality consumer franchise with strong cash generation, leadership positioning and long-term growth visibility. Buy for Bull Case Fair Value of ₹1780 (16% upside): HDFC Sec
gokulram arunasalam on Vijay Kedia’s Tweet on Gold vs. Equities Sparks a Debate on the Purpose of Wealth
gokulram arunasalam on Top 15 companies from the NSE 500 basket that provide higher dividend yields by IDBI Capital
Search for:

Recent Posts

GR Infraprojects has a Strong & Well-diversified Order Book Ensuring Revenue Visibility. Buy for target price of ₹1540 (55% upside): Axis Securities

Man Industries has stellar growth potential. Buy for target price of ₹694 (80.7% upside): SBI Securities

Crompton Greaves Consumer Electricals 3QFY26 earnings were above estimates. Buy for target price of ₹350 (43% upside): Motilal Oswal

Jubilant Pharmova has an aspirational target for FY30 of doubling of overall revenues. Buy for target price of ₹1310 (41% upside): ICICI Direct

Yatharth Hospital is well placed to deliver strong, compounding growth. Buy for target price of ₹855 (33% upside): SMIFS

You may have missed

investments

GR Infraprojects has a Strong & Well-diversified Order Book Ensuring Revenue Visibility. Buy for target price of ₹1540 (55% upside): Axis Securities

February 11, 2026 0

investments

Man Industries has stellar growth potential. Buy for target price of ₹694 (80.7% upside): SBI Securities

February 10, 2026 0

investments

Crompton Greaves Consumer Electricals 3QFY26 earnings were above estimates. Buy for target price of ₹350 (43% upside): Motilal Oswal

February 9, 2026 0

investments

Jubilant Pharmova has an aspirational target for FY30 of doubling of overall revenues. Buy for target price of ₹1310 (41% upside): ICICI Direct

February 8, 2026 0

investments

Yatharth Hospital is well placed to deliver strong, compounding growth. Buy for target price of ₹855 (33% upside): SMIFS

February 7, 2026 0

investments

Interarch Building Solutions is preponing expansions anticipating high demand. Buy for target price of ₹2850 (36% upside): ICICI Direct

February 6, 2026 0

Copyright © All rights reserved. | ChromeNews by AF themes.